Simons Foundation Autism Research Initiative (SFARI)—Maternal COVID-19 as a potential risk for autism: Supplemental funding for ongoing pregnancy cohorts
Grants awarded through this RFA will supplement funding from other agencies for ongoing pregnancy cohorts to broaden biospecimen collection and to extend post-natal family tracking. These cohorts and biospecimen collections can be leveraged in future research to understand the effects of gestational infection and inflammation on autism risk in children.
Cures Within Reach—CureAccelerator Live! Repurposing Research to Create Patient Impact in Pediatric Rare Diseases
This Request for Proposals (RFP) from Cures Within Reach is seeking clinical trials using repurposed treatments for any rare pediatric disease for an upcoming CureAccelerator Live! event. CureAccelerator Live! is a philanthropic pitch event, raising awareness of and funding for innovative repurposing research projects, with up to $50,000 funding for the winning project announced that evening. This RFP seeks clinical repurposing trials in any unsolved pediatric rare disease . A rare disease is defined by US standards as a condition that impacts fewer than 200,000 people, or by European standards as a condition than impacts less than 1 in 2,000 people.
The Fund recognizes that young investigators may find it difficult to remain in pediatric research because of a lack of funding. Therefore, the purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. The goal is to fund applicants who will go on to be independent investigators. The Fund will make up to 30 awards total with two funding cycles (15 awards each).